What is a stock summary page? Click here for an overview.
Business Description
Compare
Compare
Traded in other countries / regions
08622.Hong Kong IPO Date
2019-10-29Description
Huakang Biomedical Holdings Co Ltd is engaged in the research, development, manufacture, marketing, and sale of in-vitro diagnostic reagents and auxiliary reproductive supplies and equipment in China. Its products include Male fertility IVD reagents; Parasite antibody detection reagents; EBV antibody detection reagents; and Auxiliary reproductive supplies and equipment. The group has also diversified its business to vitamins and supplements products for the markets in the PRC, Hong Kong, and overseas.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 8.94 | |||||
| Equity-to-Asset | 0.83 | |||||
| Debt-to-Equity | 0.08 | |||||
| Debt-to-EBITDA | -0.92 | |||||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | 10.26 | |||||
| Beneish M-Score | -3.36 | |||||
| WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 33.7 | |||||
| 3-Year EPS without NRI Growth Rate | 24.6 | |||||
| 3-Year FCF Growth Rate | 39.4 | |||||
| 3-Year Book Growth Rate | -10.1 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.9 | |||||
| Quick Ratio | 4.66 | |||||
| Cash Ratio | 3.27 | |||||
| Days Inventory | 239.64 | |||||
| Days Sales Outstanding | 269.4 | |||||
| Days Payable | 57.82 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -1.5 | |||||
| Shareholder Yield % | -1.79 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 64.94 | |||||
| Operating Margin % | -35.46 | |||||
| Net Margin % | -33.02 | |||||
| ROE % | -8.11 | |||||
| ROA % | -6.64 | |||||
| ROIC % | -18.56 | |||||
| 3-Year ROIIC % | -345.31 | |||||
| ROC (Joel Greenblatt) % | -25.86 | |||||
| ROCE % | -8.05 | |||||
| Years of Profitability over Past 10-Year | 2 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 10.44 | |||||
| PB Ratio | 3.09 | |||||
| Price-to-Tangible-Book | 3.17 | |||||
| EV-to-EBIT | -29.76 | |||||
| EV-to-EBITDA | -29.76 | |||||
| EV-to-Revenue | 9.87 | |||||
| EV-to-FCF | -83 | |||||
| Price-to-Net-Current-Asset-Value | 3.55 | |||||
| Price-to-Net-Cash | 5.9 | |||||
| Earnings Yield (Greenblatt) % | -3.36 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:HUAKF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Huakang Biomedical Holdings Co Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil KYD) | |||
| EPS (TTM) (KYD) | - | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | - | ||
| 14-Day RSI | - | ||
| 14-Day ATR (KYD) | - | ||
| 20-Day SMA (KYD) | - | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range (KYD) | 0 - 0 | ||
| Shares Outstanding (Mil) | 400 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Huakang Biomedical Holdings Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Huakang Biomedical Holdings Co Ltd Stock Events
| Event | Date | Price (KYD) | ||
|---|---|---|---|---|
| No Event Data | ||||
Huakang Biomedical Holdings Co Ltd Frequently Asked Questions
What is Huakang Biomedical Holdings Co Ltd(HUAKF)'s stock price today?
The current price of HUAKF is KYD0.00. The 52 week high of HUAKF is KYD0.00 and 52 week low is KYD0.00.
When is next earnings date of Huakang Biomedical Holdings Co Ltd(HUAKF)?
The next earnings date of Huakang Biomedical Holdings Co Ltd(HUAKF) is .
Does Huakang Biomedical Holdings Co Ltd(HUAKF) pay dividends? If so, how much?
Huakang Biomedical Holdings Co Ltd(HUAKF) does not pay dividend.
Guru Commentaries on OTCPK:HUAKF
No articles.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers